Israel-based biotech start-up, BioRaptor, has announced a $3 million seed funding round to deliver artificial intelligence-generated insights to scientists.

The round was led by Israeli seed fund Lool Ventures and CPT Capital, and was joined by a number of strategic angel investors.

BioRaptor aims to help food tech and biotech companies to accelerate innovation by making AI-powered insights part of the workflow.

Across areas including alt-protein foods and pharma products, BioRaptor plans to make it easier and more cost-effective for scientists to discover, develop and scale processes on the road to commercialisation. 

Ori Zakin, BioRaptor’s co-founder and CEO, said: “Scientists are spending so much time on manual analysis rather than focusing on planning and research. As a software engineer, I’ve experienced first-hand the shift in the past 15 years and we’ve come to take for granted the work that’s been offloaded from us via advanced tools. We want to bring that to biology.”

With the funding, BioRaptor plans to accelerate development and onboard additional customers.

“As experienced investors in alternative proteins, we have seen the challenges in bringing synthetic biology products to market. Under [founders] Ori and Yaron’s leadership, we believe the BioRaptor platform can play a critical role in enabling the world’s most disruptive and innovative companies to commercialise their products in a quicker, cost-effective manner,” commented Harry Kalms, investor at CPT Capital.